SIME Diagnostics
PrivateLast Round
Grant
Jun 17, 2025
Est. Valuation
$10.67M
Total Funding Raised
$3.94M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SIME Diagnostics is a medical technology company that develops AI-powered point-of-care diagnostic platforms for acute and intensive care settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Biotechnology
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SIME Diagnostics Comparables
Compare SIME Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nostics | 76% | |
| Etiometry | 73% | |
| NeoPrediX AG | 69% |
SIME Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 17, 2025 | ||||
| Seed | Jun 10, 2024 | ||||
| Seed | May 12, 2020 | ||||
| Grant | Jan 11, 2018 | ||||
| Accelerator | May 30, 2016 |
SIME Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consilience Ventures | Seed |
| Oxford Technology | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 33% MoM, reaching 4.6K.
- Apr 8, 2026
Monthly visitors grew 68% MoM.
SIME Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SIME Diagnostics's valuation, stock price, and market status.
Is SIME Diagnostics a public or private company?
SIME Diagnostics is a private company.
What is the current stock price of SIME Diagnostics?
SIME Diagnostics is a private company, so its shares have no public market price. Caplight tracks SIME Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SIME Diagnostics worth (valuation)?
SIME Diagnostics's valuation is estimated at $10.7M based on funding round data.
Can I buy SIME Diagnostics stock?
SIME Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SIME Diagnostics's last funding round?
SIME Diagnostics's most recent funding round was Grant on June 17, 2025.
Who are the main investors in SIME Diagnostics?
Key investors in SIME Diagnostics include Consilience Ventures, Oxford Technology.
Will SIME Diagnostics IPO soon?
No public IPO plans have been announced for SIME Diagnostics.
How can I track SIME Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in SIME Diagnostics's shares on secondary markets.